A Phase 3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol in Adults With an Open Label Study in Adolescents to Evaluate the Efficacy and Safety of Induction and Maintenance Therapy With Icotrokinra in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol in Adults With an Open Label Study in Adolescents to Evaluate the Efficacy and Safety of Induction and Maintenance Therapy With Icotrokinra in Participants With Moderately to Severely Active Ulcerative Colitis
The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes inflamed and develops tiny open ulcers).
Inclusion Criteria:
Exclusion Criteria:
Participate-In-This-Study1@its.jnj.com844-434-4210
AAI, C1425BGC, Argentina
CABA, C1061AAS, Argentina
Caba, C1405, Argentina
Liège, 4000, Belgium
Ribeirão Preto, 14051140, Brazil
Edmonton, Alberta T5R 1W2, Canada
Cheng Du Shi, 610041, China
Luoyang, 471000, China
Taian, 271000, China
Praha 1- Mala Strana, 118 33, Czechia
Surat, 395002, India
Negrar-Verona, 37024, Italy
Fujiidera-shi, 583-0027, Japan
Higashiibaraki-gun, 311-3193, Japan
Kitakyushu, 807-8556, Japan
Nishinomiya Shi, 663 8501, Japan
Sumida Ku, 130 8575, Japan
Sunto-gun, 411-8611, Japan
Poznan, 60 354, Poland
Cluj-Napoca, 400394, Romania
Allingsas, 441 83, Sweden
Istanbul, 34890, Turkey (Türkiye)
Istanbul, 34899, Turkey (Türkiye)
Greater Manchester, BL9 7TD, United Kingdom